Cargando…
MON-LB045 Inaccurate Hemoglobin A1c in a Transman Patient with Diabetes: Implications for Treatment and Surveillance
Background: HbA1c is the standard biomarker to monitor glycemic control and to prevent diabetes complications. Conditions (hemolysis, reticulocytosis), or drugs (erythropoietin, dapsone), known to affect the lifespan of red blood cells have an impact on HbA1c’s accuracy. Testosterone therapy (TT) is...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Endocrine Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550844/ http://dx.doi.org/10.1210/js.2019-MON-LB045 |